JVJosef Vormoor

Josef Vormoor

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josef Vormoor has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew G. Hall

    Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication
  • Daniel Williamson

    Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication
  • Deepali Pal

    Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom

    1 shared publication
  • Julie Irving

    Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication
  • Kerrie Wilson

    Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication
  • Klaus Rehe

    Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK

    1 shared publication

Latest Publications

  • Dormancy Stems the Tide of Chemotherapy

    by Deepali Pal, Olaf Heidenreich, Josef Vormoor


  • Open Access

    Acute B lymphoblastic leukaemia‐propagating cells are present at high frequency in diverse lymphoblast populations

    by Klaus Rehe, Kerrie Wilson, Simon Bomken, Daniel Williamson, Julie Irving, Monique L. Den Boer, Martin Stanulla, Martin Schrappe, Andrew G. Hall, Olaf Heidenreich, et al.

    Leukaemia‐propagating cells are more frequent in high‐risk acute B lymphoblastic leukaemia than in many malignancies that follow a hierarchical cancer stem cell model. It is unclear whether this characteristic can be more universally applied to patients from non‐‘high‐risk’ sub‐groups and across a broad range of cellular immunophenotypes. Here, we demonstrate in a wide range of primary patient samples and patient samples previously passaged through mice that leukaemia‐propagating cells are found in all populations defined by high or low expression of the lymphoid differentiation markers CD10, CD20 or CD34. The frequency of leukaemia‐propagating cells and their engraftment kinetics do not differ between these populations. Transcriptomic analysis of CD34 high and CD34 low blasts establishes their difference and their similarity to comparable normal progenitors at different stages of B‐cell development. However, consistent with the functional similarity of these populations, expression signatures characteristic of leukaemia propagating cells in acute myeloid leukaemia fail to distinguish between the different populations. Together, these findings suggest that there is no stem cell hierarchy in acute B lymphoblastic leukaemia. →See accompanying article 10.1002/emmm.201202207